Cancer Institute– A national cancer institute
designated cancer center

Billy W. Loo, Jr., MD, PhD, DABR

Back to Profile

Publication Details

  • Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.

    Tang C, Murphy JD, Khong B, La TH, Kong C, Fischbein NJ, Colevas AD, Iagaru AH, Graves EE, Loo BW, Le QT. Int J Radiat Oncol Biol Phys. 2012; 83 (5): 1514-20

    We have previously reported that metabolic tumor volume (MTV) obtained from pretreatment (18)F-fluorodeoxydeglucose positron emission tomography (FDG PET)/ computed tomography (CT) predicted outcome in patients with head-and-neck cancer (HNC). The purpose of this study was to validate these results on an independent dataset, determine whether the primary tumor or nodal MTV drives this correlation, and explore the interaction with p16(INK4a) status as a surrogate marker for human papillomavirus (HPV).

    PubMedID: 22270174

Stanford Medicine Resources:

Footer Links: